Juan Vila, MD
NPI 1932196151 · Cardiovascular Disease Physician · Carolina, PR
Enrolled with Medicare as Practitioner - Cardiovascular Disease (cardiology) · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1932196151
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 13993 (PR)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
595 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Technetium Tc-99m Sestamibi, Diagnostic, Per Study DoseA9500 | 154 | $114 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report93000 | 125 | $14 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 106 | $125 |
| Exercise Or Drug-Induced Heart Stress Test With Electrocardiogram (ecg) With Supervision and Review By Physician93015 | 78 | $62 |
| Nuclear Medicine Studies of Heart Muscle at Rest and With Stress and Spect78452 | 75 | $426 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 82 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Rosuvastatin Calcium | 1,471 | 318 |
| Amlodipine Besylate | 1,374 | 286 |
| Metoprolol Succinate | 1,221 | 229 |
| Atorvastatin Calcium | 1,191 | 263 |
| Valsartan/Hydrochlorothiazidebrand: Valsartan-Hydrochlorothiazide | 738 | 148 |
| Valsartan | 686 | 150 |
| Hydrochlorothiazide |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$718 across 27 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-10-03
- Last updated
- 2014-12-29
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.